Literature DB >> 20010963

Bone: causes of low bone mass in breast cancer-time for action?

Robert E Coleman, Jennifer S Walsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20010963     DOI： 10.1038/nrendo.2009.244

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  9 in total

1.  Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).

Authors:  P Hadji; M Gottschalk; V Ziller; M Kalder; C Jackisch; U Wagner
Journal:  Maturitas       Date:  2006-10-17       Impact factor: 4.342

2.  Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women.

Authors:  E Lundgren; J Rastad; E Thrufjell; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1997-03       Impact factor: 3.982

Review 3.  Hyperparathyroidism.

Authors:  William D Fraser
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

Review 4.  Cancer treatment-induced bone loss in breast and prostate cancer.

Authors:  Fred Saad; Jonathan D Adachi; Jacques P Brown; Leah A Canning; Karen A Gelmon; Robert G Josse; Kathleen I Pritchard
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

5.  Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis.

Authors:  Pauline M Camacho; Amit S Dayal; Josefina L Diaz; Fadi A Nabhan; Monica Agarwal; John G Norton; Patricia A Robinson; Kathy S Albain
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

6.  Practical guidance for the management of aromatase inhibitor-associated bone loss.

Authors:  P Hadji; J-J Body; M S Aapro; A Brufsky; R E Coleman; T Guise; A Lipton; M Tubiana-Hulin
Journal:  Ann Oncol       Date:  2008-04-29       Impact factor: 32.976

7.  Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.

Authors:  David M Reid; Julie Doughty; Richard Eastell; Steven D Heys; Anthony Howell; Eugene V McCloskey; Trevor Powles; Peter Selby; Robert E Coleman
Journal:  Cancer Treat Rev       Date:  2008-06-02       Impact factor: 12.111

8.  Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.

Authors:  G Bruce Mann; Y Chiu Kang; Caroline Brand; Peter R Ebeling; Julie A Miller
Journal:  J Clin Oncol       Date:  2009-06-22       Impact factor: 44.544

9.  Calcium plus vitamin D supplementation and the risk of breast cancer.

Authors:  Rowan T Chlebowski; Karen C Johnson; Charles Kooperberg; Mary Pettinger; Jean Wactawski-Wende; Tom Rohan; Jacques Rossouw; Dorothy Lane; Mary Jo O'Sullivan; Shagufta Yasmeen; Robert A Hiatt; James M Shikany; Mara Vitolins; Janu Khandekar; F Allan Hubbell
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.